cyclothiazide has been researched along with aniracetam in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (36.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Tullio, P; Delarge, J; Diouf, O; Dupont, L; Lebrun, P; Lepagnol, J; Lestage, P; Morain, P; Pirotte, B; Podona, T; Somers, F; Spedding, M | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| England, PM; Fleming, JJ | 1 |
| Ahmed, AH; Oswald, RE | 1 |
| Grove, SJ; Jamieson, C; Maclean, JK; Morrow, JA; Rankovic, Z | 1 |
| Hampson, A; Harris, C; Li, YX; Marrs, C; Mueller, R; Nielsson, L; Rachwal, S; Rogers, G; Ulas, J; Zhong, S | 1 |
| Chaudhary, A; Johansen, TH; Verdoorn, TA | 1 |
| Camici, O; Corazzi, L; Fallarino, F; Fioretti, MC; Genazzani, AA; L'Episcopo, MR; Nicoletti, F; Silla, S | 1 |
| Boxall, AR; Garthwaite, J | 1 |
| Mayer, ML; Wong, LA | 1 |
| Fleck, MW; Mayer, ML; Partin, KM | 1 |
| Lu, T; Shen, Y; Yang, XL | 1 |
| Arvigo, D; Bonfanti, A; Pittaluga, A; Raiteri, M | 1 |
| Iino, M; Nakagawa, T; Ozawa, S; Sekiguchi, M; Wada, K | 1 |
| Bódi, I; Gueritaud, J; Kapus, G; Pataki, A; Székely, JI; Tarnawa, I | 1 |
| Closier, M; Iop, F; Lestage, P; Lockhart, B | 1 |
| Bolshakov, KV; Buldakova, SL; Magazanik, LG; Tikhonov, DB | 1 |
| Croucher, MJ; Patel, DR; Young, AM | 1 |
| Lei, S; MacDonald, JF; Orser, BA; Reynolds, JN; Thatcher, GR | 1 |
| Baumbarger, P; Muhlhauser, M; Nisenbaum, ES; Yang, CR | 1 |
| Aoki, S; Nishikawa, K; Sekiguchi, M; Wada, K | 1 |
| Benardo, LS; Ling, DS | 1 |
| Clark, S; Dudman, JT; Gouaux, E; Jin, R; Partin, KM; Weeks, AM | 1 |
| Gouliaev, AH; Harpsøe, K; Liljefors, T; Peters, D; Varming, T | 1 |
| Xu-Friedman, MA; Yang, H | 1 |
25 other study(ies) available for cyclothiazide and aniracetam
| Article | Year |
|---|---|
4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic aci
Topics: Adenosine Triphosphate; Allosteric Regulation; Animals; Benzothiadiazines; Cerebral Cortex; Cyclic S-Oxides; Diazoxide; Drug Design; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Insulin; Insulin Antagonists; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred DBA; Oocytes; Potassium Channels; Rats; Rats, Wistar; Receptors, AMPA; RNA, Messenger; Solubility; Stereoisomerism; Structure-Activity Relationship; Thiadiazines; Xenopus laevis | 1998 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.
Topics: Allosteric Regulation; Animals; Binding Sites; Ligands; Receptors, AMPA | 2010 |
Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.
Topics: Allosteric Regulation; Binding Sites; Humans; Mutagenesis, Insertional; Nootropic Agents; Piracetam; Pyrrolidinones; Receptors, AMPA; X-Ray Diffraction | 2010 |
Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor.
Topics: Allosteric Regulation; Animals; Benzamides; Benzothiadiazines; Binding Sites; Excitatory Amino Acid Agents; Humans; Indazoles; Ligands; Models, Molecular; Protein Conformation; Receptors, AMPA; Sulfonamides | 2010 |
Benzoxazinones as potent positive allosteric AMPA receptor modulators: part I.
Topics: Allosteric Regulation; Animals; Benzoxazines; Molecular Structure; Nootropic Agents; Prosencephalon; Pyrrolidinones; Rats; Receptors, AMPA; Structure-Activity Relationship | 2011 |
Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Excitatory Amino Acid Antagonists; Humans; Pyrrolidinones; Receptors, AMPA; Receptors, Kainic Acid; Recombinant Proteins; Xenopus laevis | 1995 |
[3H]aniracetam binds to specific recognition sites in brain membranes.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Binding Sites; Brain; Cells, Cultured; Cerebellum; Glutamic Acid; Male; Membranes; Phorbol 12,13-Dibutyrate; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tritium | 1995 |
Synaptic excitation mediated by AMPA receptors in rat cerebellar slices is selectively enhanced by aniracetam and cyclothiazide.
Topics: Animals; Benzothiadiazines; Cerebellum; In Vitro Techniques; Pyrrolidinones; Rats; Rats, Wistar; Receptors, AMPA; Stimulation, Chemical; Synaptic Transmission | 1995 |
Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors.
Topics: Alanine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzothiadiazines; Concanavalin A; Ganglia, Spinal; Hippocampus; Ibotenic Acid; In Vitro Techniques; Kainic Acid; Neurons; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid | 1993 |
AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate.
Topics: Alternative Splicing; Amino Acid Sequence; Antihypertensive Agents; Benzothiadiazines; Cell Line; Fetus; Fibroblasts; Humans; Ion Channel Gating; Kidney; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Patch-Clamp Techniques; Pyrrolidinones; Receptors, AMPA; Sensitivity and Specificity; Thiocyanates | 1996 |
Modulation of desensitization at glutamate receptors in isolated crucian carp horizontal cells by concanavalin A, cyclothiazide, aniracetam and PEPA.
Topics: Animals; Aspartic Acid Endopeptidases; Benzothiadiazines; Concanavalin A; Goldfish; Nootropic Agents; Patch-Clamp Techniques; Pyrrolidinones; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid | 1999 |
Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antihypertensive Agents; Benzothiadiazines; Dioxoles; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Heterocyclic Compounds; Hippocampus; In Vitro Techniques; Kynurenic Acid; Male; N-Methylaspartate; Nootropic Agents; Norepinephrine; Piperidines; Pyrrolidinones; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Tritium | 1999 |
Potentiating effects of 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyaceta mide (PEPA) on excitatory synaptic transmission in dentate granule cells.
Topics: Animals; Antihypertensive Agents; Aspartic Acid Endopeptidases; Benzothiadiazines; Dentate Gyrus; Excitatory Amino Acids; Male; Neurons; Nootropic Agents; Pyrrolidinones; Rats; Rats, Wistar; Synapses; Synaptic Transmission | 1999 |
Differential modulation of the GYKI 53784-induced inhibition of AMPA currents by various AMPA-positive modulators in cerebellar Purkinje cells.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzodiazepines; Benzothiadiazines; Cells, Cultured; Cerebellum; Dioxoles; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Membrane Potentials; Piperidines; Purkinje Cells; Pyrrolidinones; Rats; Receptors, AMPA | 2000 |
(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzodiazepines; Benzothiadiazines; Calcium; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Frontal Lobe; Hippocampus; In Vitro Techniques; Male; Norepinephrine; Pyrrolidinones; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Stereoisomerism; Tetrodotoxin; Tritium | 2000 |
Ca2+-dependent desensitization of AMPA receptors.
Topics: Adamantane; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alternative Splicing; Animals; Animals, Newborn; Antihypertensive Agents; Benzothiadiazines; Calcium; Calcium Signaling; Dose-Response Relationship, Drug; Glutamic Acid; Hippocampus; Kainic Acid; Neurons; Nootropic Agents; Pyrrolidinones; Rats; Receptors, AMPA | 2000 |
Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Antihypertensive Agents; Benzodiazepines; Benzothiadiazines; Calcium; Carbon Radioisotopes; Corpus Striatum; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Kynurenic Acid; Male; Microdialysis; Nootropic Agents; Potassium; Presynaptic Terminals; Pyrrolidinones; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Tritium | 2001 |
Positive allosteric modulators of AMPA receptors reduce proton-induced receptor desensitization in rat hippocampal neurons.
Topics: Allosteric Regulation; Animals; Benzothiadiazines; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Hydrogen-Ion Concentration; Ion Channel Gating; Nerve Tissue Proteins; Neurons; Nitrates; Patch-Clamp Techniques; Protons; Pyrrolidinones; Rats; Rats, Wistar; Receptors, AMPA; Wheat Germ Agglutinins | 2001 |
LY392098, a novel AMPA receptor potentiator: electrophysiological studies in prefrontal cortical neurons.
Topics: Action Potentials; Animals; Benzothiadiazines; Diuretics; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Agonists; Male; Neurons; Prefrontal Cortex; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Sodium Chloride Symporter Inhibitors; Sulfonamides; Thiophenes | 2001 |
A desensitization-selective potentiator of AMPA-type glutamate receptors.
Topics: Allosteric Regulation; Animals; Benzothiadiazines; In Vitro Techniques; Kinetics; Oocytes; Patch-Clamp Techniques; Phenoxyacetates; Pyrrolidinones; Rats; Receptors, AMPA; Xenopus | 2002 |
Nootropic agents enhance the recruitment of fast GABAA inhibition in rat neocortex.
Topics: Animals; Antihypertensive Agents; Benzothiadiazines; Cognition; Concanavalin A; Evoked Potentials; Neocortex; Neural Inhibition; Nootropic Agents; Pyramidal Cells; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2005 |
Mechanism of positive allosteric modulators acting on AMPA receptors.
Topics: Allosteric Regulation; Benzothiadiazines; Binding Sites; Cell Line; Crystallography; Dimerization; Drug Synergism; Electric Conductivity; Humans; Ligands; Molecular Conformation; Oxazines; Patch-Clamp Techniques; Protein Structure, Tertiary; Pyrrolidinones; Receptors, AMPA; Time Factors | 2005 |
Identification of a putative binding site for 5-alkyl-benzothiadiazides in the AMPA receptor dimer interface.
Topics: Allosteric Site; Animals; Benzothiadiazines; Computer Simulation; Dimerization; In Vitro Techniques; Mice; Models, Molecular; Oxazines; Protein Structure, Quaternary; Pyrrolidinones; Receptors, AMPA; Structure-Activity Relationship | 2007 |
Relative roles of different mechanisms of depression at the mouse endbulb of Held.
Topics: Animals; Benzothiadiazines; Cochlear Nucleus; Diuretics; Excitatory Postsynaptic Potentials; In Vitro Techniques; Mice; Mice, Inbred CBA; Models, Neurological; Neuronal Plasticity; Neurons; Nootropic Agents; Pyrrolidinones; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2008 |